SEP 28, 2017 10:00 AM PDT

WEBINAR: Development of anti-cancer gene therapies through understanding of cytokine-induced programmed cell death

Speaker
  • PhD Candidate; Lehman College, City University of New York; The Graduate Center, City University of New York
    Biography
      Leah is passionate about understanding the the molecular signaling pathways of new anti-cancer therapeutics. She is a City University of New York (CUNY) Science Scholar working in Dr. Moira Sauane's cancer research lab at Lehman College in The Bronx, NY. She is a PhD candidate from the CUNY Graduate Center.

      Leah completed undergraduate degrees in biology and forensic science from the University of New Haven in Connecticut. As an undergraduate, Leah performed research on highly specific DNA nucleases for gene therapy at Justus Liebig University in Giessen, Germany, which ignited her interest in molecular biology research and therapeutics.

      As a mentor, she is able to share her passion for science research and encourage undergraduate and high school students to pursue careers in STEM fields.

    Abstract

    DATE: September 28, 2017
    TIME: 10:00am PDT, 1:00pm EDT

     

    The use of gene therapy is well studied due to its potential to treat cancer, the second leading cause of death worldwide. The goal of gene therapy is to introduce functional genetic material into human cells to be transcribed and translated in order to regulate, repair or suppress a molecular mechanism that contributes to a disease state. Compared to traditional cancer therapies such as surgery, chemotherapy or radiation therapy, gene therapy is a more personalized and targeted approach because it is based on understanding the genetic profile of a patient’s tumor. Genes being developed for cancer therapy code for a variety of proteins including tumor suppressors, specific antigens, transcription factors, cell cycle regulators, receptors and cytokines. The cytokine Interleukin-24 (IL-24), is of special interest for gene therapy because of its selective killing effect on numerous cancer cell types while having no effect on corresponding normal cells. Due to this property, IL-24 is being investigated in Phase II clinical trials as a gene therapeutic to treat cancer patients. To understand how IL-24 exerts its specific killing effect, our lab studies the signaling pathways that IL-24 activates to induce programmed cell death also known as apoptosis. We use various cancer cell lines to understand which proteins IL-24 modulates to produce its killing effect. Currently, we are exploring how IL-24 blocks protein synthesis in cancer cells to promote cell death. Our aim is to further develop IL-24 as an anti-cancer therapeutic for gene therapy and to reveal targets for combination therapies that will work synergistically with IL-24 to produce a cancer specific killing effect.

    Learning Objectives:

    • Understand how cell lines are used to decipher molecular signaling pathways for the development of anti-cancer therapeutics
    • Learn how IL-24 treatment kills cancer cells

    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    APR 21, 2021 5:00 PM CEST
    APR 21, 2021 5:00 PM CEST
    Date: April 21, 2021 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Spatial Answers Trilogy - Spatial Answers in Immunology Immunology Researchers share their Spatial Discoveries in SARS-C...
    DEC 16, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 16, 2020 8:00 AM PST
    Date: December 16, 2020 Time: 8:00am (PST), 11:00am (EST) Molecular imaging of living specimens offers a means to draw upon the growing body of high-throughput molecular data to better under...
    SEP 28, 2017 10:00 AM PDT

    WEBINAR: Development of anti-cancer gene therapies through understanding of cytokine-induced programmed cell death


    Specialty

    Cancer Research

    Molecular Biology

    Cell Biology

    Immunology

    Genetics

    Cancer Therapeutics

    Biotechnology

    Cancer Diagnostics

    Molecular Diagnostics

    Biochemistry

    Biomarkers

    Cell Culture

    Laboratory Testing

    Dna

    Oncology

    Geography

    North America59%

    Europe16%

    Asia12%

    South America5%

    Africa3%

    Registration Source

    Website Visitors100%

    Job Title

    Student24%

    Research Scientist12%

    Executive9%

    Educator/Faculty7%

    Scientist7%

    Medical Laboratory Technician7%

    Facility/Department Manager6%

    Lab Management6%

    Post Doc5%

    Medical Doctor/Specialist5%

    Clinical Laboratory Scientist4%

    Marketing/Sales2%

    Biologist2%

    QC/QA2%

    Microbiologist1%

    Engineer1%

    Organization

    Academic Institution11%

    Clinical Laboratory7%

    Hospital6%

    Biotech Company5%

    Research Institute5%

    Pharmaceutical Company4%

    Medical School3%

    Government3%

    Ambulatory Care2%

    Life Science Company1%

    Medical Center1%

    Industrial Company1%

    Contract Research Organization (Cro)1%

    Consultant1%

    Other6%


    Show Resources
    Loading Comments...
    Show Resources